Work

Evaluation of regulator of G-protein signaling 2 (RGS2) at different stages of prostate cancer - Significance and clinical potential

Year: 2019
Type: dissertation
Abstract: Prostate cancer (PC) is often a slow-growing and symptom-free disease with good prognosis.\nHowever, a substantial number will progress, ultimately metastasize if left untreated and\nfinally kill the patient. The standard treatment for these stages of PC is androgen deprivation\ntherapy (ADT), which generally has an initially good clinical response. However, ADT drives\ndevelopment of highly aggressive forms of castration-resistant PC (CRPC) and promote\ndevelopment of bone metastases. Thus, early detection of resistance is invaluable considering\nthe incurability of these stages once they are established.\nThe purpose of the present thesis was to assess the regulation and significance of regulator of\nG-protein signaling (RGS2) in PC; with focus on PC progression, and development of CRPC and\nbone metastases. Furthermore, evaluate its potential as a prognostic biomarker for hormonenaïve\nprostate cancer (HNPC) and in association to development and progress of CRPC. This, as\nthe new era of treatment options calls for stable reliable biomarkers for adequate treatment\ndecisions.\nThe principal findings from this work suggest that, RGS2 was highly expressed in both\nadvanced HNPC and CRPC. The significance of this was reflected by the association between\nhigh levels of RGS2 and poor clinical outcome in both of these stages. Moreover, experimental\ndata suggest that RGS2 expression is regulated by hypoxia and HIF1. The implication of\ndifferent levels of RGS2 was assessed with RGS2 knockdown in the PC cell line LNCaP. The\nresults show that low and high RGS2 expressing PC cells have distinct PC phenotypes,\nresembling early low-risk tumors and advanced PC, respectively. Furthermore, the data\nsuggests that by mediating the effect of hypoxia, RGS2 has significant tumor promoting roles in\nHNPC. Additionally, induced RGS2 expression, in response to ADT, was found predictive of\ndecreased time to relapse in association with resumed androgen-receptor (AR) signaling. The\nstromal expression of RGS2 display a contrasting expression pattern compared to the\nepithelial, with decreased expression in association with more advanced disease, the relevance\nof this was suggested by a prognostic property of stromal RGS2 expression. Finally, high RGS2\nexpression levels were noticed in human PC bone metastases, and found to be essential for\nthe tumor cells ability to establish in the bone, as well as endorsing of the sclerotic phenotype\nthat is associated with PC bone metastases.\nIn conclusion, the present thesis suggests a tumor-promoting function for RGS2, associated\nwith PC progress and development of CRPC and PC bone metastases. Furthermore, the results\nsuggest that RGS2 has potential as a prognostic and treatment-predictive biomarker in PC.
Author: Anna Linder
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W2946205966
Cites: 128
Cited by:
Related to: 10